IG15114 - ePlatform for a “test bed” tool across EU for antimicrobial coating solutions in health care entering to the market

Worldwide, millions of patients are affected annually by healthcare-associated infection (HCAI), impacting up to 80,000 patients in European Hospitals on any given day. One potential solution to prevent HCAIs involves antimicrobial coatings (AMCs) on surfaces. To solve burden issues with HCAIs system (lost resources, injuries and deaths, increase of antimicrobial resistance), dynamics science is required to be able to test real life application of antimicrobial coatings in a healthcare setting. The CIG will develop an open access AMiCI ePlatform, which is a process innovation. CIG aims for a “fast track” from innovation to market without additional risk to human or environment, neither development of antimicrobial resistance (AMR).

CIG organizes 4 meetings: 1) Kick off by CIG team and three World café workshops on formulation of the AMICI ePlatform. CIG will have bootcamp for 12 ECI with coating innovations of business potential, 4 STSMs on AMC’s in aspect of from innovation innovations to market, and 4 ITC conference grant for students with coating innovations. CIG team uses a chunk of effort to dissemination activities: often and regular. Dissemination consists of ePlatform formulation, webpage updates, social media open access publications.

The AMiCI ePlatform is built based on detailed information and facts on AMC challenges and opportunities from industry and health care. The AMiCI ePlatform is jointly defined, created, tested and improved as continuously process to ensure it is applicable to real life testing settings and business plan. The ePlatform will provide tools to prove the efficacy of coatings and real steps for field/full scale testing in pilot hospitals. CIG will have focus on early career investigators (ECI) with coating innovations to support career development, special focus will be scientists from ITC e.g. to make business plans. ePlatform for a “test bed” tool across EU will be linked to certain real-life tests sites, each providing specific strengths for development and testing.